top of page


International Centre for Genomic Medicine in Neuromuscular Diseases

Screenshot 2022-04-13 at 22.12.49.png

What is the ICGNMD?

The ICGNMD works for people with Neuromuscular Diseases (NMDs) and their families. 

  • Bring together experts from all over the world to collaborate in diganosis and research in NMDs

  • Train medical professionals who work with NMDs in genomic medicine, in their own countries 

  • Work to increase global access to genomic medicine, so more patients' care can be informed by genetic information

  • Build a diverse world-wide cohort of patients with NMDs and their families, and increase their access to clinical trials.

Screenshot 2022-04-13 at 22.31.49.png
Screenshot 2022-04-13 at 22.31.33.png
Screenshot 2022-04-13 at 22.32.21.png
Screenshot 2022-04-13 at 22.32.03.png
Screenshot 2022-04-13 at 22.35.10.png


  • Create a transcontinental genomics research and capacity building partnership between the UK and Official Development Assistance Lower and Middle Income Countries (ODA-LMICs) which include Brazil, India, South Africa, Turkey and Zambia

  • Discover new disease genes, understand comparative genetic architecture and explore disease mechanisms

  • Increase the number of patients with an accurate genetic diagnosis, build trial-ready cohorts, and ultimately improve health outcomes for patients with neuromuscular diseases drawn from a population of over 1.5 billion

Learn More

For further information about the ICGNMD please click here

Screenshot 2022-04-13 at 17.28.18.png
bottom of page